Rapid Molecular Subtyping for Precision Oncology
New AI 'Hetairos' Diagnoses Brain Tumors in Minutes
Researchers at the DKFZ unveil an AI tool that identifies over 100 molecular tumor subtypes with high speed and accuracy.
A medical computer screen in a lab displaying a brain scan with tumor analysis data and a progress bar showing completion.
Photo: Avantgarde News
Researchers at the German Cancer Research Center (DKFZ) developed a new AI system named Hetairos [1]. The tool identifies over 100 molecular subtypes of brain and spinal cord tumors within minutes [1][2]. This represents a significant advancement over current diagnostic methods [3].
Traditional molecular testing usually requires up to two weeks to produce results [2]. Hetairos can complete the same analysis in approximately 12 minutes [2]. In clinical tests, the AI significantly outperformed human pathologists in both diagnostic speed and accuracy [1][3].
This speed allows doctors to start targeted treatments much earlier in the care process [2]. The system provides a level of detail previously difficult to achieve in such a short timeframe [1]. This breakthrough could lead to improved outcomes for patients with central nervous system tumors [2][3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View allTopics
About the author
Avantgarde News Desk covers rapid molecular subtyping for precision oncology and editorial analysis for Avantgarde News.
